Condition (MeSH)
Thyroid Dysgenesis
ClinicalTrials.gov lists 2 trials for Thyroid Dysgenesis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
5 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Thyroid Dysgenesis itself; the rest are tagged with a narrower condition beneath it.
When did Thyroid Dysgenesis trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2013 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Thyroid Dysgenesis trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Not applicable | 2 |
How many Thyroid Dysgenesis trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Thyroid Dysgenesis? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Congenital hypothyroidism in children with eutopic gland or thyroid hemiagenesis: prognostic factors for transient vs. permanent hypothyroidism. | Journal of pediatric endocrinology & metabolism : JPEM | 2023 | Yes |
| Approach to the Patient With Congenital Hypothyroidism. | The Journal of clinical endocrinology and metabolism | 2022 | Yes |
| TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | EMBO molecular medicine | 2018 | Yes |
| Mutations in BOREALIN cause thyroid dysgenesis. | Human molecular genetics | 2017 | Yes |
| Congenital hypothyroidism. | Orphanet journal of rare diseases | 2010 | Yes |
Showing 5 of 7 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.